Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangeline R Jackson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Trends in Cancer|March 11, 2026
The redox paradox in HGGs: ROS as drivers and destroyersPooja Kumari, Zacary P Germon, Evangeline R Jackson, et al.
Proteomics|July 23, 2019
Signal Transduction in Diffuse Intrinsic Pontine GliomaRyan J Duchatel, Evangeline R Jackson, Frank Alvaro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2024
Current status and advances to improving drug delivery in diffuse intrinsic pontine gliomaLauren M Arms, Ryan J Duchatel, Evangeline R Jackson, et al.
Neuro-Oncology|February 2, 2026
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Oncogene|November 11, 2021
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategiesIzac J Findlay, Geoffry N De Iuliis, Ryan J Duchatel, et al.
Neuro-Oncology|August 17, 2023
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-alteredEvangeline R Jackson, Mika L Persson, Cameron J Fish, et al.
Molecular Cancer Research : MCR|September 27, 2022
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric CancersTabitha McLachlan, William C Matthews, Evangeline R Jackson, et al.
Clinical Proteomics|December 19, 2022
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selectionDilana E Staudt, Heather C Murray, David A Skerrett-Byrne, et al.
Neoplasia (New York, N.Y.)|August 21, 2023
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine gliomaAlyssa Noll, Carrie Myers, Matthew C Biery, et al.
Neuro-Oncology Advances|January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine gliomaRyan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Trends in Cancer|March 11, 2026
The redox paradox in HGGs: ROS as drivers and destroyersPooja Kumari, Zacary P Germon, Evangeline R Jackson, et al.
Proteomics|July 23, 2019
Signal Transduction in Diffuse Intrinsic Pontine GliomaRyan J Duchatel, Evangeline R Jackson, Frank Alvaro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2024
Current status and advances to improving drug delivery in diffuse intrinsic pontine gliomaLauren M Arms, Ryan J Duchatel, Evangeline R Jackson, et al.
Neuro-Oncology|February 2, 2026
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Oncogene|November 11, 2021
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategiesIzac J Findlay, Geoffry N De Iuliis, Ryan J Duchatel, et al.
Neuro-Oncology|August 17, 2023
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-alteredEvangeline R Jackson, Mika L Persson, Cameron J Fish, et al.
Molecular Cancer Research : MCR|September 27, 2022
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric CancersTabitha McLachlan, William C Matthews, Evangeline R Jackson, et al.
Clinical Proteomics|December 19, 2022
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selectionDilana E Staudt, Heather C Murray, David A Skerrett-Byrne, et al.
Neoplasia (New York, N.Y.)|August 21, 2023
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine gliomaAlyssa Noll, Carrie Myers, Matthew C Biery, et al.
Neuro-Oncology Advances|January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine gliomaRyan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Pageof 2